immunotherapy
209 projects
H2020Individual fellowship2015–2017Denmark
MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion
H2020Individual fellowship2015–2017Netherlands
CR-PHAGOCYTOSIS · Complement-mediated phagocytosis in neutrophils
H2020Individual fellowship2015–2017Belgium
ImmunoFarm · IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli.
H2020Individual fellowship2015–2017Netherlands
CARiPSCTcells · Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application
2 partners
H2020Individual fellowship2015–2018United Kingdom
WORMTUMORS · Worm power: Can helminths modify the development of colorectal cancer?
2 partners · 2 countries
H2020Individual fellowship2015–2017United Kingdom
DC cancer · Development and immunological control of dendritic cell cancer
2 partners
H2020Individual fellowship2015–2017United Kingdom
Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment
H2020Doctoral network2015–2018Spain
IMMUNOSHAPE · Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells
16 partners · 6 countries
H2020Doctoral network2015–2018Italy
TOLLerant · Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
10 partners · 5 countries
FP7Individual fellowship2015–2017Germany
HIV-NOPA · Assessment of functional immune responses of HIV infected individuals without protective HLA-B alleles
FP7Individual fellowship2014–2016Ireland
RA AND GD T CELLS · The effect of retinoic acid on the fate of γδ T cells
FP7Reintegration grant2013–2017Spain
PRR IN IMMUNOTHERAPY · COMBINATIONAL USE OF INNATE IMMUNE RECEPTORS FOR CANCER IMMUNOTHERAPY
FP7Staff exchange2013–2016Austria
MODICELL · Targeted Modulation of Immune-System Responses in Cell Therapies
5 partners · 3 countries
FP7Reintegration grant2012–2016Italy
STEMIMMUNE · Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells
FP7Reintegration grant2012–2016France
T9CAN · Transcriptional regulation of IL-9-producing CD4 T cells: use in cancer immunotherapy
FP7Individual fellowship2011–2013France
3ITD · Impact of IL-7 and IFNa on nTreg development
FP7Reintegration grant2010–2014Czechia
GCPII_SYSTEM · Design and development of novel reagents, tools, and techniques targeting human glutamate carboxypeptidases II and III
FP7Reintegration grant2010–2012Greece
NILTHERA · Novel Interleukins for immunotherapy of Asthma
FP7Reintegration grant2009–2013Sweden
CHEMO-IMMUNE THERAPY · A translational approach evaluating novel strategies using chemotherapy to enhance immune-mediated anti-tumor activity
FP7Individual fellowship2008–2011France
NK-APC-TREG X-TALK · Cross-talk between NK, APC and regulatory T cells
FP7Individual fellowship2008–2010Sweden
GIFT · Graft engineering to improve allogeneic stem cell transplantation
FP6Individual fellowship2007–2009Greece
IMMUNOEPIGENETICS · Anti-tumour CD8 immunity influenced by epigenetic alterations
FP6Individual fellowship2006–2008Switzerland
LY49-AUTOIMMUNITY · Regulation of immune responses and autoimmunity by activating and inhibitory NK receptors expressed by T lymphocytes: role of ITAM versus ITIM signal balance
FP6Doctoral network2006–2009Austria
NK DEFENSE AND THERAPY · Natural killer cell-mediated anti-viral and anti-tumour defence and therapy: Integrated research training in molecular medicine, bioinformatics and issues of patent application and the SME biotech business
12 partners · 7 countries